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Abstract We performed a systematic review and meta-analysis of randomized controlled trials
that studied the conservative management of stress urinary incontinence (SUI). There
were 1058 results after the initial searches, from which 37 studies were eligible
according to previously determined inclusion criteria. For the primary outcomes, pelvic
floor muscle training (PFMT) was more efficacious than no treatment in improving
incontinence-specific quality of life (QoL) scales (SMD ¼ 1.24SDs; CI 95% ¼ 1.77 to
0.71SDs). However, its effect on pad tests was imprecise. Combining biofeedback
with PFMT had an uncertain effect on QoL (MD ¼ 4.4 points; CI 95% ¼ 16.69 to
7.89 points), but better results on the pad test, although with elevated heterogeneity
(MD ¼ 0.9g; 95%CI ¼ 0.71 to 1,10g); group PFMT was not less efficacious than
individual treatment, and home PFMT was not consistently worse than supervised
PFMT. Both intravaginal and superficial electrical stimulation (IES and SES) were better
than no treatment for QoL and pad test. Vaginal cones had mixed results. The
association of IES with PFMT may improve the efficacy of the latter for QoL and pad
test, but the results of individual studies were not consistent. Thus, there is evidence of
the use of PFMT on the treatment of SUI, with and without biofeedback.
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Introduction
Urinary incontinence (UI) is a very common condition among
women, with reported annual incidences of 1% to 35%1, and a
lifetime risk of surgery of 11% to 13%.2,3 Its impact on quality
of life is significant, leading to physical and social limitations,
shame, and increased rates of depressive symptoms.4 Stress
urinary incontinence (SUI) is the most common subtype of
UI, and its treatment is predominantly surgical, particularly
after the introduction of synthetic midurethral slings in the
mid-nineties, which led to less invasive surgical procedures.
Despite its efficacy, surgical treatment may lead to compli-
cations, directly or indirectly related to the use of synthetic
materials.5 Therefore, conservative treatment is considered
the first-line option for managing women with SUI.6
However, multiple alternatives are available, such as
pelvic floor muscle training (PFMT), bladder training, elec-
trical stimulation and vaginal cones, and the relative efficacy
between all these options is not well documented. We have
retrieved a few systematic reviewswithmeta-analysiswhich
addressed the comparison between PFMT andno treatment,7
and PFMT plus an alternative treatment versus that alterna-
tive treatment alone.8 However, the objective of this review
is different from the previously published systematic re-
views; we aimed to pool randomized trials which compared
multiple forms of conservative treatment (alone or in asso-
ciation) between each other, with control groups or surgical
treatments, emphasizing treatment options that are avail-
able in Brazil due to the lack of guidelines for these
practitioners.
Methods
We entered a protocol for this review, which is currently
registered in the PROSPERO database (CRD42015020645;
available at: www.crd.york.ac.uk/PROSPERO/display_re-
cord.asp?ID¼CRD42015020645).
Only randomized controlled trials (RCTs)were considered
eligible. We excluded other study designs (such as cohorts,
case-controls, quasi-randomized trials).Wehave also chosen
to consider aminimal methodological quality as an inclusion
criteria, and have used the Jadad scale9 for classifying the
RCTs. Studies that obtained a score lower than three in such
scale were not considered eligible for inclusion due to a
higher risk of bias.
The target population was formed by adult women,
aged 18 years or older, with a clinical diagnosis of SUI
(complaint, and/or an observation during examination of
urinary leakage due to effort or straining), with absence of
neurological injuries or diseases. Urodynamic diagnosis of
SUI was not considered necessary for inclusion. Studies
that comprised women with urgency urinary inconti-
nence or mixed urinary incontinence were excluded, since
these diagnoses differ significantly from SUI, and the
observed response to treatment could also be significantly
different.
The interventions were any forms of conservative treat-
ment for SUI, compared against each other, either alone or
in combination with one another. Studies which assessed
treatments or devices unavailable in Brazil were not
included.
Variables
Primary outcomes were: incontinence-related quality of life,
measured through validated instruments, such as the Kinǵs
Health Questionnaire (KHQ) and the Incontinence Quality of
Life Questionnaire (I-QoL); objective measure of inconti-
nence, quantified in grams through pad-tests.
Secondary outcomes: Number of incontinence episodes,
measured through bladder diaries; Subjective improvement,
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measured through visual scales, such as Likert scales, or
through the number of satisfied patients; General quality of
life, measured through non-specific instruments, such as SF-
36; Adverse events.
Study Search and Selection
We performed searches for RCTs in the following electronic
databases: Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE, and LILACS. We then imported the
results to EndNote reference management software (Thom-
son Reuters, New York, U.S.A.). We adapted the search
strategy according to the rules of each database, using the
following elements: (stress urinary incontinence) OR (stress
incontinence) AND ((treatment) OR (therapy)) AND (conser-
vative) OR (medical) OR (physical therapy) OR (physiother)
OR (electrical stimulation) OR (PFMT) OR (training) OR
(estrogen)). Furthermore, we used the “Cochrane highly
sensitive filter for detecting RCTs” in the MEDLINE search
by adding the following elements to the search strategy:
(randomized controlled trial[pt]) OR (controlled clinical trial
[pt]) OR (randomized[tiab]) OR (placebo[tiab]) OR (clinical
trials as topic[mesh:noexp]) OR (randomly[tiab]) OR (trial
[ti]) NOT ((animals[mh] NOT (humans[mh] AND animals
[mh])))).
There were no restrictions on language or year of publi-
cation; we searched all the databases from their inception up
to the search date. Two study authors (RMM and LGB)
performed the initial screening independently, by reading
titles and abstracts and locating potentially eligible entries.
Then, the same two authors obtained and analyzed indepen-
dently the full text of each potentially eligible result, to
determine true eligibility. Any disagreements between the
two authors were resolved by consulting a third author
(PSM).
Data Collection and Extraction
Data extracted from the publications of eligible studieswere:
country, institution, conflicts of interest, ethical approval,
participants’ consent, data collection period, inclusion and
exclusion criteria, characteristics of participants, treatments,
and outcomes of interest. Two authors (RMM and LGB)
performed data extraction independently by using a data
extraction form developed and pilot-tested by the authors.
Statistical Analyses
We used a statistical package (RevMan 5.3, Nordic Cochrane
Center, Copenhagen, Denmark) to perform the analysis. We
summarized binary outcomes (such as subjective improvement
measured through the number of satisfied patients; adverse
events) using Mantel-Haenszel relative risks (RR). We preferred
RRover odds ratios (OR) due to its easier interpretation. Howev-
er, we have used Peto OR in situations with zero number of
events in one of the groups, because it is the most accurate
measure in such situations.10 We summarized continuous out-
comes(all theotheroutcomesof interest–qualityof lifescores in
multiple scales; pad test weights; number of incontinence
episodes; visual analog scales) using the mean difference
(MD), calculated through the inverse variance method.10 Preci-
sion of estimates appear as 95% confidence intervals (95%Cis).
Wequantifiedstatisticalheterogeneitybyusing I2, and informed
its value together with the estimates. When we measured a
single continuous outcome using different scales in different
studies (such as incontinence-specific quality of life measured
throughdifferent instruments),wesummarized theoutcomeby
using the standardized mean difference (SMD). SMDs are not
expressed in the original outcome scale, but in standard devia-
tions (SDs), which are interpreted as follows: SMD between 0.2
and 0.5 SD indicates a small effect; between 0.5 and 0.8 SD, a
moderate effect; and larger than 0.8 SD, a large effect.10
Through meta-analyses, we pooled measures of single
outcomes reported by different studies that addressed simi-
lar comparisons between conservative treatment methods.
We expressed pooled data graphically through forest-plots,
in which an increase in the measure of an outcome is shown
to the right of the central line, and such an increase may be
beneficial (such as an increase in a certain quality of life scale
score) or harmful (such as an increase in the number of
episodes of incontinence). We chose to pool the studies in
which the interventions were actually comparable and in
which the study groups were also comparable before the
interventions. We evaluated statistical heterogeneity, ex-
pressed by the I2 value for eachmeta-analysis; we considered
it elevated when higher than 50%. In situations of elevated
heterogeneity, we reevaluated the individual studies to
assure that we were actually studying interventions and
populations that were comparable. If they were indeed
similar, we chose to perform random effects meta-analyses.
Quality of Included Studies
The Jadad scale9was used to judge themethodological quality
of individual studies and previously described. Two authors
(RMM and LGB) independently assessed the methodological
quality of individual studies, giving an appropriate to score
each study. The two authors resolved disagreements through
discussion or by consulting a third author (PSM).
Results
We performed electronic searches on May 10th 2015 and
obtained a total of 1058 hits: 590 from MEDLINE, 364 from
CENTRAL, and 104 from LILACS. Furthermore, we located one
additional entry through the revision of reference lists from
other similar reviews. The study selectionprocess is illustrated
in a PRISMA flowchart presented in ►Fig. 1. ►Table 1 shows
the characteristics of included studies. Pooled data are repre-
sented in ►Figs. 2 and 3. The interventions included in this
review are the following: Pelvic floor muscle training (PFMT);
Biofeedback; Bladder training; Electrical stimulation; Vaginal
cones; Magnetic stimulation; and Paula method.
Pelvic Floor Muscle Training (with or without
Biofeedback) versus No Treatment
Three eligible studies studied such a comparison, which
included a total of 122 patients, 59 in the PFMT groups
and 66 in the control groups.11–13
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Incontinence-specific quality of life – two studies11,12
reported this outcome, the first one measuring it using the
King’s Health Questionnaire (KHQ – higher scores are worse)
and the second using IIQ-7 (higher scores are better – we
inverted the direction of effect in the meta-analysis to allow
combination with KHQ results). Meta-analysis (►Fig. 2A)
demonstrated a moderate to large effect of PFMT toward a
better score in incontinence-specific scales.
Pad-test (g) – one study12 reported that there was no
sufficient precision in the study to distinguish a beneficial
outcome from a harmful effect of PFMT.
• Number of incontinence episodes – one study12 demon-
strated a beneficial effect of PFMT: a decrease in the
number of incontinence episodes.
• General quality of life – one study measured this out-
come13 through the Quality of Life Scale (QoLS), and
although there was a tendency toward a beneficial effect,
the result was not sufficiently precise to distinguish a
harmful, null, or beneficial effect of PFMT.
PFMT versus PFMT Plus Biofeedback
Five studies were eligible14–18, which included 250 wom-
en, 126 in the PFMT groups and 124 in the PFMT, in
addition to biofeedback groups. One of them15 was not
included in the meta-analyses for some of the outcomes
because its groups were heterogeneous at the beginning of
the study, and the use of final measures only in the pooled
estimates would not take this initial difference between
groups into consideration.
• Incontinence-specific quality of life – one studymeasured
this with the KHQ.17 Considering the domain incontinence
impact, the study was not sufficiently precise to distin-
guish a beneficial, a harmful or a null effect of the
association of PFMT with biofeedback, when compared
with PFMT alone.
• Pad test (g) – A meta-analysis of four studies14,16–18
(►Fig. 3A) resulted in a sufficiently precise estimate
demonstrating higher urine loss in the PFMT groups,
when compared with PFMT þ biofeedback, suggesting a
better effect from the combined treatment. Although this
result was statistically significant, it does not seem to have
a large clinical relevance, since the increase in losses
documented through the pad test were only around 1 g
more in the PFMT group. Also, such result is due, primari-
ly, to the result of a single study.14 If such a study is
excluded from the meta-analysis, the estimate from the
three other studies becomes imprecise.
• Number of incontinence episodes – one study calculated
this,17 but it was not precise enough to distinguish a
better, a worse or an indifferent effect when comparing
PFMT þ biofeedback with PFMT alone.
• Subjective improvement – two studies reported this
outcome,14,18 the first one using a visual analog scale (0
to 10) and the second one using a Likert scale (0 to 4). The
combination of their resultswas not sufficiently precise to
demonstrate whether combined treatment was better,
worse, or indifferent when compared to PFMT alone.
• Adverse events – three studies reported adverse
events.15,17,18 There was not enough precision to distin-
guish any difference from a larger number of adverse
events in any of the groups when comparing PFMT alone
with combined treatment.
Fig. 1 Flowchart demonstrating the process of searching, screening,
and selecting eligible studies.
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Table 1 Characteristics of the included studies
Study Country Treatments com-
pared
Treatment
duration
Patients analyzed
per group
Diagnosis of
incontinence
Jadad scale
Ahlund et al48 Sweden Postpartum su-
pervised PFMT vs
written instruc-
tions for PFMT
postpartum
24 wk. 40 / 42 Clinical 3 (2 / 0 / 1)
Aksac et al14 Turkey Home PFMT vs
Home PFMT þ BF
vs Control
8 wk. 20 / 20 / 10 UD 3 (2 / 0 / 1)
Aukee et al15 Finland Home PFMT vs
Home PFMT þ BF
12 wk. 15 / 15 UD 3 (2 / 0 / 1)
Berghmanset al16 Holland Supervised PFMT
vs Supervised
PFMT þ BF
4 wk. 20 / 20 Clinical and/or UD 4 (2 / 1 / 1)
Bo et al23 Norway Home PFMT (12
contr. 3x/day) vs
Supervised
(45min/wk.) and
home PFMT
24 wk. 29 / 23 UD and pad test 3 (2 / 0 / 1)
Bo et al35 Norway Supervised PFMT
vs IES (50Hz;
30min/day) vs
Cones (20min/
day) vs Control
24 wk. 25 / 25 / 27 / 30 UD and pad test 4 (2 / 1 / 1)
Bo et al13 Norway Home and super-
vised PFMT vs
Control
24 wk. 25 / 30 UD 3 (2 / 0 / 1)
Borello et al20 USA Supine PFMT vs
Supine and stand-
ing PFMT
9 to 12 wk. 17 / 19 Clinical 3 (2 / 0 / 1)
Cammu et al42 Belgium PFMT þ BF
(30min 1x/wk.) vs
Cones (15min. 2x/
day)
12 wk. 30 / 30 UD 3 (2 / 0 / 1)
Castro et al36 Brazil Supervised PFMT
vs IES(50Hz;
20min/day) vs
Cones (25min 3x/
wk.) vs Control
24 wk. 26 / 27 / 24 / 24 UD 4 (2 / 1 / 1)
Correia et al37 Brazil SES (50Hz; 20min;
2x/wk.) vs IES
(50Hz; 20min; 2x/
wk.) vs Control
6 wk. 15 / 15 / 15 Clinical 3 (2 / 0 / 1)
De Oliveira
et al21
Brazil Group PFMT
(45min, 2x/wk) vs
Individual super-
vised PFMT
(30min, 2x/wk)
12 wk. 30 / 30 UD 4 (2 / 1 / 1)
Dumoulin et al46 Canada Supervised PFMT
vs Supervised
PFMT þ abdomi-
nal training vs
Control
8 wk. 20 / 23 / 19 UD and pad test 4 (2 / 1 / 1)
Felicissimo
et al24
Brazil Home PFMT (90 a
180 contr./day) vs
Supervised PFMT
(50min, 2x/wk) þ
Home PFMT
8 wk. 30 / 29 UD 3 (2 / 0 / 1)
(Continued)
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Table 1 (Continued)
Study Country Treatments com-
pared
Treatment
duration
Patients analyzed
per group
Diagnosis of
incontinence
Jadad scale
Ferreira et al25 Portugal Home PFMT (30
contr./day) vs Su-
pervised (45min.
1x/wk) þ home
PFMT
24 wk. 17 / 17 UD 3 (2 / 0 / 1)
Fitz et al11 Brazil PFMT þ BF
(40min 2x/wk) vs
Control
4 wk. 16 / 16 UD 3 (2 / 0 / 1)
Gilling et al50 New Zealand Magnetic stimu-
laion (10-50Hz,
20min, 3x/wk) vs
Placebo/Sham
6 wk. 35 / 35 UD 4 (2 / 1 / 1)
Harvey et al43 Canada Supervised þ
home PFMT vs
Cones
6 wk. 7 / 7 UD 3 (2 / 1 / 0)
Hirakawa et al17 Japan Home PFMT (2x/
day) vs Home
PFMT þ BF (2x/
day)
12 wk. 23 / 23 Clinical 3 (2 / 0 / 1)
Kamel et al45 Egypt Abdominal train-
ing (3x/wk) vs Su-
pervised PFMT
(3x/wk)
12 wk. 15 / 15 UD 3 (2 / 0 / 1)
Kaya et al29 Turkey Bladder training vs
PFMT þ bladder
training
6 wk. 24 / 26 Clinical 3 (2 / 0 / 1)
Knight et al31 UK Supervised IES
(35Hz; 35 min; 1x/
10days) vs Home
IES (10Hz, daily
during night
sleep) vs Home
PFMT (6x/day)
24 wk. 19 / 20 / 18 UD 3 (2 / 0 / 1)
Liebergall et al49 Israel Paula Method
(45min/day) vs
Group þ home
PFMT
12 wk. 117 / 123 Pad test 3 (2 / 1 / 0)
Luber et al34 USA IES (50Hz; 15min,
2x/day) vs Place-
bo/Sham
12 wk. 20 / 24 UD 3 (2 / 1 / 0)
McLean et al12 Canada Supervised þ do-
mestic PFMT vs
Control
12 wk. 18 / 17 UD 3 (2 / 0 / 1)
Miller et al27 USA Pre-contraction
(“Knack”) vs
Control
1 wk. 13 / 14 Clinical 3 (2 / 0 / 1)
Morkved et al18 Norway Supervised and
domestic PFMT vs
Supervised and
domestic
PFMT þ BF
24 wk. 48 / 46 UD and pad test 4 (2 / 1 / 1)
Parsons et al32 UK PFMT þ IES vs
PFMT þ placebo
vs PFMT þ control
14 wk. 82 / 42 / 40 / 20 UD 3 (1 / 1 / 1)
Pereira et al22 Brazil Group PFMT (2x/
wk, 60 min) vs
12 wk. 15 / 15 / 15 Clinical 3 (2 / 0 / 1)
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Beyond these five mentioned studies, a sixth study as-
sessed the use of biofeedback,19 but made a somewhat
different comparison, and thus was not included in the
quantitative analyses.
Supine and Standing PFMT versus Supine Only PFMT
This comparison was performed by one eligible study,20
which included 36 women, 19 in the supine and standing
PFMT group, and 17 in the supine only PFMT group.
• Incontinence-specific quality of life – this outcome was
assessed using the IIQ scale (higher scores are worse). The
result was not sufficiently precise to distinguish a better,
worse, or indifferent effect when combining both posi-
tions, compared with supine only PFMT.
• Pad test (g) – Likewise, the result was imprecise to detect
any significant difference between the combination of
positions and supine only PFMT.
• Number of incontinence episodes – there was no suffi-
cient precision to detect any significant difference be-
tween using both positions, or only the supine position
during PFMT.
Individual PFMT versus Group PFMT
Two studies were eligible.21,22 They included 90 women, 45
in the individual PFMT groups and 45 in the PFMT groups.We
included both studies in the quantitative analyses for at least
one outcome.
• Incontinence-specific quality of life – both studies as-
sessed this outcome using KHQ (higher scores are worse).
Meta-analysis (►Fig. 2B) resulted in an imprecise esti-
mate to determine whether individual PFMT is better,
worse, or indifferent when compared to the PFMT group
for this outcome.
Table 1 (Continued)
Study Country Treatments com-
pared
Treatment
duration
Patients analyzed
per group
Diagnosis of
incontinence
Jadad scale
Individual PFMT
(2x/wk, 60 min) vs
Control
Pereira et al40 Brazil SES (50Hz;
20 min; 2x/wk.) vs
Control
6 wk. 7 / 7 Clinical 3 (2 / 0 / 1)
Pereira et al41 Brazil PFMT (40 min; 2x/
wk.; 100 contr.) vs
Cones (40 min.;
2x/wk.)
6 wk. 13 / 15 / 15 Clinical 3 (2 / 0 / 1)
Sand et al39 USA IES (2x/d; fre-
quency not re-
ported) vs
Placebo/Sham
12 wk. 28 / 16 UD 4 (2 / 1 / 1)
Santos et al44 Brazil IES (50Hz; 20 min;
2x/wk.) vs Cones
(2x/wk; 45 min.)
16 wk. 24 / 21 Clinical 3 (2 / 0 / 1)
Sherburn et al30 Australia Supervised þ
home PFMT vs
Bladder training
20 wk. 41 / 35 UD 5 (2 / 2 / 1)
Terlikowski et al33 Poland PFMT þ IES
(40Hz; 20 min; 2x/
day) vs PFMT þ
placebo/sham
8 wk. 64 / 29 UD 3 (2 / 0 / 1)
Wong et al19 China PFMT þ vaginal BF
(2x/wk; 30min) vs
PFMT þ abdomi-
nal BF (to mini-
mize abdominal
contractions)
12 wk. 19 / 19 UD 3 (2 / 0 / 1)
Zanetti et al26 Brazil Home PFMT vs
Supervised þ
home PFMT (2x/
wk; 45min.)
12 wk. 21 / 23 UD 3 (2 / 0 / 1)
Abbreviations: BF, biofeedback; IES, intravaginal electrical stimulation; PFMT, pelvic floor muscle training; SES, surface electrical stimulation; UD,
urodynamics; Wk., weeks.
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• Pad test (g) – both studies showed that the pooled esti-
mate (►Fig. 3B) was not precise enough to determine
whether individual PFMT was superior or indifferent
when compared with the PFMT group.
• Number of incontinence episodes – only one study re-
ported this outcome21 and its estimate was not precise
enough to detect any difference between individual and
the group PFMT.
• Subjective improvement (number of satisfied women) –
both studies reported this outcome.Meta-analysis resulted
in an imprecise estimate to distinguish a superior effect
(higher number of satisfiedwomen), from an inferior effect
(lower number of satisfied women) or from no difference
when comparing individual PFMTwith group PFMT.
Home PFMT versus Intensive PFMT with
Physiotherapist
Four studies assessed this comparison,23–26 including a total
of 189 women, 97 in the home PFMT groups and 92 in the
intensive PFMT groups. All four studies were included in the
quantitative analyses for at least one outcome.
• Incontinence-specific quality of life – three studies re-
ported this outcome,24–26 but the combination of indi-
vidual results through meta-analysis was not possible.
One of themassessed the outcome using theDitrovie scale
(higher scores represent a worse quality of life)25 The
study estimatewas not sufficiently precise to determine if
intensive PFMT was more effective, less effective or no
different from home PFMT. Another study used the ICIQ-
SF scale and demonstrated an equivalent improvement in
both groups (final median in the intensive group ¼ 8
points (5 to 13) / in the home PFMT group ¼ 8 points (6
to 12); p ¼ 0.7).24 The third study, on the other hand,
demonstrated better results in the intensive PFMT group
using the I-QoL scale for assessment, in which higher
scores represent a better quality of life (median in the
intensive group ¼ 89 points / in the home PFMT group
¼ 79 points; p ¼ 0.04).26
• Pad test – two studies assessed this outcome,24,26 both
reporting it with medians only, which did not allow the
calculation of combined estimates. Individual study re-
sults are, thus, reported. In the first study,24 the final
median in the intensive group was 3.2 g (1.2 g to 8 g),
while in the home PFMT was 2.8 g (1.5 g to 8.5 g);
p ¼ 0.78; there was no significant difference between
the groups. In the second study26 the final median in
the intensive group was 3.2 g, while in the home PFMT it
was 15 g; p ¼ 0.0018; the intensive group had signifi-
cantly less urine loss on the pad test.
• Number of incontinence episodes – one study reported
that this estimate25 was not sufficiently precise to deter-
mine if intensive PFMT was more efficacious, less effica-
cious or no different from home PFMT.
• Subjective improvement (number of women with signifi-
cant improvement or cure) – three studies reported this
outcome.23,24,26 A pooled estimate from all three studies
was precise enough to determine an inferior effect of
home PFMTwhen compared with intensive PFMT, with a
significantly inferior number of satisfied women in the
home PFMT groups. A high heterogeneity was observed in
this meta-analysis, which was related to a single study,24
which, differently from the other two studies, did not find
any significant difference between the groups. If this
single study is excluded, the heterogeneity is solved,
and the estimate still demonstrates a better effect in the
intensive PFMT group.
Use of a Pre-contraction (Knack) versus No Maneuver
A single study27 compared the use of a pre-contraction right
before a physical effort, versus the same effort without a pre-
contraction, including 27 women, 13 in the pre-contraction
group, and 14 in the no maneuver group.
• Pad test – only this outcome was studied for this compar-
ison. The authors performed a modified test, in which a
paper towel was used, and the area of the spot resulting
fromwetting the towelwasmeasured in cm2. There was a
strong tendency of the pre-contraction to be associated
with a smaller wetted area, but the estimate was impre-
cise to distinguish a beneficial, a harmful or a null effect
from performing a pre contraction.
PFMT versus Bladder Training (with or without
Associated PFMT)
This comparison was assessed by two studies,28–30 which
included a total of 126 women, 61 in the PFMT group and 65
in the bladder training group. The results of these studies
were not combined, because one of them reported its results
using only medians. Individual study results are thus re-
ported here, for each informed outcome.
• Incontinence-specific quality of life – one study30 as-
sessed this outcome using the ICIQ-SF scale (higher scores
indicate worse quality of life) and the estimate was
precise enough to indicate a higher quality of life after
treatment with PFMT. Other studies28,29 used the IIQ-7
scale (higher scores indicate worse quality of life) – there
was a median decrease in IIQ-7 score equal to 19 (9.5 to
42.8) in the PFMT group, and equal to 7.1 (0 to 28.5) in the
bladder training group; there was higher quality of life in
the PFMT group at the end of the study.
• Pad test– one study30 reported final median values with a
95%CI demonstrating significantly lower urine loss in the
PFMT group (median in the FMT group ¼ 0.1 g; 95%CI
¼ 0.3 g to 3.1 g; 41 women / median in the bladder
training group ¼ 0.5 g; 95%CI 1 g to 3.4 g; p ¼ 0.03).
• Number of episodes of incontinence – one study30 had an
estimate which was not sufficiently precise to distinguish
a larger, lower or indifferent number of episodes of loss in
the PFMT group, when compared with the bladder train-
ing group.
• Subjective improvement (visual analog scale for bother– 0
to 10) – one study30 presented an estimate which pre-
cisely demonstrated better results in the PFMT group,
with higher scores in the bother scale observed in the
bladder training group.
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Fig. 2 Meta-analyses for the outcome “Incontinence-specific quality of life. (A) PFMT vs control; (B) Group PFMT vs individual PFMT; (C)
Intravaginal electrical stimulation vs control; (D) Superficial electrical stimulation vs control; (E) Vaginal cones vs control; (F) PFMT vs vaginal
cones; (G) Intravaginal electrical stimulation vs vaginal cones. Abbreviations: SD, standard deviation; IV, inverse variance; IES, intravaginal
electrical stimulation; SES, superficial electrical stimulation.
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Fig. 3 Meta-analyses for the outcome “Pad test” (A) PFMTvs PFMT þ biofeedback; (B) Group PFMTvs individual PFMT; (C) Intravaginal electrical
stimulation vs control; (D) Superficial electrical stimulation vs control; (E) Vaginal cones vs control; (F) PFMT vs vaginal cones; (G) Intravaginal
electrical stimulation vs vaginal cones. Abbreviations: SD, standard deviation; IV, inverse variance; IES, intravaginal electrical stimulation; SES,
superficial electrical stimulation.
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• General quality of life – one study30 used the AQoL scale
(higher scores indicate worse quality of life), and there
was not enough precision to distinguish a beneficial,
harmful or indifferent effect when comparing bladder
training to PFMT.
PFMT Plus Intravaginal Electrical Stimulation (IES)
versus PFMT Alone
This comparison was assessed by three studies,31–33 includ-
ing a total of 253 women, 166 in the PFMT þ IES group and
87 in the PFMT group. One of these studies34 did not report
detailed quantitative results, thus the estimates of the other
two studies are reported for all given outcomes.
• Incontinence-specific quality of life – one study33 used
the I-QoL scale (higher scores indicate better quality of
life) and there was a precise estimate indicating better
results in the PFMT þ IES.
• Pad test– one study33 demonstrated a sufficiently precise
estimate suggesting lower urine loss in the PFMT þ IES
group. Another study31 reported a median loss of 0.8 g (0
to 88 g) in the PFMT group and of 1.5 g (0 to 28 g) in the
PFMT þ IES group, with significant differences between
the two groups.
• Number of episodes of incontinence – one study33 dem-
onstrated a significantly lower number of episodes in the
PFMT þ IES group.
• Subjective improvement (number of satisfied women) –
one study31 demonstrated a tendency in the PFMT þ IES
group to have a higher proportion of satisfiedwomen, but
the estimate was not sufficiently precise to be significant.
One of the three studies assessing this outcome did not
report quantitative data,32 but it concluded that therewas
no significant difference in the pad test or KHQ measures
when combining IES with PFMT. However, in this study,
we performed IES at home, and it could have suffered a
lower adherence.
Intravaginal Electrical Stimulation (IES) versus Control
This comparisonwas reported by five studies34–39, including
221 women, 115 in the IES groups and 106 in the control
groups.
• Incontinence-specific quality of life – this outcome was
reported by two studies40–42, which have used the KHQ
and I-QoL scales, respectively. Meta-analysis (►Fig. 2C) of
the estimates has shown a large effect of IES toward a
better score in the quality of life scales, when compared
with the control groups.
• Pad test – reported by four studies.35–39 The pooled
estimate (►Fig. 3C) demonstrated a significantly lower
urine loss in the IES group, although with elevated statis-
tical heterogeneity. The heterogeneity was related to one
of the studies35, which reported the most imprecise
estimate and which did not detect a difference between
the groups.
• Number of incontinence episodes – reported by four
studies34–36,39, with three of them included in a meta-
analysis. A pooled estimate was sufficiently precise to
indicate a beneficial effect of IES,when comparedwith the
control groups. Again, one study35 did not detect a signif-
icant difference between the two groups, and such study
is the main source of heterogeneity in this meta-analysis.
The fourth study34 not included in the pooled estimate for
not reporting detailed quantitative results, did not detect
a difference between IES and the use of sham vaginal
probe.
• Subjective improvement – two studies34,36 reported this
outcome, measuring it by the number of satisfiedwomen,
and they did not detect a significant difference between
the groups. Another two studies35,39 measured this out-
come using a bother visual analog scale, but their results
were not pooled due tovery high heterogeneity. They both
demonstrated lower bother scores in the IES groups.
• Adverse events – reported by two studies,35,39 therewas a
tendency towards a higher number of adverse events in
the IES groups, but the estimate was not sufficiently
precise.
Surface Electrical Stimulation (SES) versus Control
Two studies including a total of 44 women, 22 in each group,
assessed this comparison.38,40
• Incontinence-specific quality of life – a pooled estimate
from both studies (►Fig. 2D), both also using the KHQ
scale, evidenced a better result in the SES group, when
compared with the control group.
• Pad test – meta-analysis combining the results of both
studies (►Fig. 3D) demonstrated a precise estimate suggest-
ing lower losses at the pad test in groups treated with SES.
Vaginal Cones versus Control
Such comparison was assessed by three studies35,36,41, in-
cluding a total of 135 women, 66 in the vaginal cone groups
and 69 in the control groups.
• Incontinence-specific quality of life – this outcome was
reported by two studies36,41, which used the KHQ and the
I-QoL scales, respectively. Pooled estimate from both
studies (►Fig. 2E) was sufficiently precise to demonstrate
that the use of vaginal cones results in better quality of life
scores.
• Pad test – all three studies reported this outcome, and a
combined estimate was not precise enough (►Fig. 3E) to
distinguish no effect from a beneficial effect after using
vaginal cones, when compared with the control groups.
• Number of incontinence episodes – reported by two
studies35,36; a combination of their results, however,
was not precise enough to distinguish if there was a
beneficial effect, a harmful one or no effect when using
vaginal cones, compared with the control groups. Individ-
ually, one of the studies35 did not demonstrate a signifi-
cant difference between de groups (95%CI ¼  1.56 to
2.56 episodes), while the other36 demonstrated better
results after using vaginal cones (95%CI ¼  9.92 to
4.98 episodes).
• Subjective improvement (number of satisfied women) –
reported by only one study36, therewas evidence of better
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results when using vaginal cones, with a larger number of
satisfied women.
PFMT versus Vaginal Cones
Five studies assessed this comparison35,36,41–43, including
204 women, 101 in the PFMT groups and 103 in the vaginal
cones groups.
• Incontinence-specific quality of life – three studies re-
ported this outcomes36,41,43, two of them quantitative-
ly.36,41 Meta-analysis of the results from these two last
studies (►Fig. 2F) was imprecise to distinguish whether
using PFMT had a superior, inferior or indifferent effect
when compared with the use of vaginal cones. The third
study43 did not inform quantitative results, but also
concluded that there was no significant difference be-
tween the groups.
• Pad test – reported by four studies35,36,41,43, meta-analy-
sis of the results for this outcome (►Fig. 3F) was not
sufficiently precise to determinewhether using PFMT had
a better, worse or indifferent result when compared with
vaginal cones.
• Number of incontinence episodes – reported by three
studies35,36,43, whose combined estimates was not pre-
cise enough to determine whether the use of PFMT has a
superior, inferior or indifferent effect when compared
with vaginal cones.
• Subjective improvement (number of women with signifi-
cant improvement). Two studies36,41 reported there was
not enough precision in the pooled estimate to distinguish
a better, worse, or indifferent result for this outcome after
using PFMT, when compared to vaginal cones.
• Adverse events – two studies35,43 reported adverse events
with a pooled estimate indicating a significantly lower
number of these events in the PFMT groups.
Intravaginal Electrical Stimulation (IES) versus Vaginal
Cones
Three studies assessed this comparison,35,36,44 including a
total of 148women, 76 in the IES groups and 72 in the vaginal
cones groups.
• Incontinence-specific quality of life – two studies re-
ported this outcome36,44, both using the I-QoL scale. A
combined estimate (►Fig. 2G) was not sufficiently precise
to distinguish a beneficial, harmful or indifferent effect of
IES when compared with vaginal cones.
• Pad test – three studies reported this outcome35,36,44, and
the combination of their results (►Fig. 3G)was not precise
enough to determine whether IES had a superior, inferior
or indifferent effect when compared with vaginal cones.
• Subjective improvement (number of patients with signif-
icant improvement) – outcome reported by two stud-
ies35,36, whose combined estimates was not able to
precisely determine whether IES was better than, worse
than or equal to vaginal cones.
• Adverse events – only one study reported this outcome35,
and its estimate was imprecise to demonstrate any signif-
icant difference between the groups.
PFMT versus Abdominal Training
Two studies evaluated the training of the transverse abdominal
muscles, one in an isolated fashion,45 and the other in combi-
nationwith PFMT,46,47 and both comparing it with PFMT alone.
The first study45 did not report any of the outcomes of interest
for this review (it only reported urodynamic measures and
vaginal pressure measures) but it concluded that abdominal
training was more effective than PFMT in relation to these
outcomes. The studywas limitedby the fact that itonly included
obese women with SUI. The second study46–48 reported its
quantitative results in medians only, but concluded that the
association of abdominal training to PFMT did not have any
additional benefit when compared with PFMT alone (women
with pad test < 2 g after treatment ¼ 70% in the PFMT group
and 73% in the abdominal þ PFMT group).
Specifically Oriented PFMT for Postpartum SUI versus
General Theoretical Postpartum Instructions
One study38 compared the use of an initial supervised
training followed by home PFMT, with reassessments by a
physical therapist every six weeks, versus the use of
general theoretical postpartum instructions for PFMT,
without practical orientation andwithout the prescription
of a specific program. The study did not report any of the
outcomes of interest of this review, but was limited to
reporting outcomes associatedwithmuscle strength (peri-
neometry Oxford scale). The authors concluded that both
groups had equivalent improvements, with no significant
difference between them.
PFMT versus the Paula Method
Only one study assessed this comparison,49 including 176
women, 84 in the PFMT group and 92 in the Paula method
group.
• Incontinence-specific quality of life – the study had a
statistically precise estimate suggesting better quality of
life scores with the Paulamethod. Clinically, however, this
result may translate into an effect that goes from no
clinically significant difference between the treatments
up to better results with the Paula method.
• Pad test – the study estimate was not precise to distin-
guish if the PFMT had a better, worse or equal effect
compared with the Paula method.
Magnetic Stimulation (MS) with PFMT versus PFMT
Alone
Only one study made this comparison,50 including 70
women, 35 in the MS þ PFMT group and 35 in the PFMT
group.
• Incontinence-specific quality of life – the study used the I-
QoL scale and there was insufficient precision in the
estimate to determine whether the association of MS
with PFMT is better, worse or no different, when com-
pared with PFMT alone.
• Pad test – the study estimate was also imprecise to
distinguish if MS þ PFMTwas better than or no different
from PFMT alone.
RBGO Gynecology and Obstetrics Vol. 38 No. 2/2016
Conservative Treatment of Stress Urinary Incontinence Moroni et al.108
Discussion
In this systematic review with meta-analysis of eligible
studies, we tried to perform a very broad search, with the
objective of locating any comparisons that involved the use
of conservative treatments for SUI. We set a minimal meth-
odological quality as the inclusion criterion, due to a very
large predicted number of results before starting the
searches. We were able to pool the results of individual
studies into combined estimates using meta-analyses for
various comparisons and outcomes of interest, generating
estimates that comprise a larger number of participants
when compared to the estimates of the original studies.
Although we made an effort to pool only effectively similar
comparisons, we encountered a great deal of variability in
the characteristics of interventions along different studies,
even when studies were assessing a same kind of interven-
tion (e.g., studies assessing PFMT, inwhich one study uses an
exercise program executed multiple times a day, while
another study uses a similar program, but executed only
once a day). Due to this variability, we observed significant
statistical heterogeneity in some comparisons and out-
comes. Acknowledging such potential source for heteroge-
neity, when performing meta-analyses in such cases, we
used random-effect meta-analyses, which takes into account
this variability among studies. Various studies did not report
their outcomes in a way that could be used to performmeta-
analyses, and these cases, we tried to report their individual
results in a descriptive way.
The results of this review demonstrate that PFMT exer-
cises are efficacious for treating SUI, being better than no
treatment and resulting in higher quality of life indexes. Such
observation agrees with other systematic reviews that stud-
ied this theme,7 but attention should paid to the fact that
most studies which used urodynamic evaluations when
screening potential participants excluded women with evi-
dence of sphincter deficiency. This was probably due to the
fact that these women have a smaller potential of improve-
ment with conservative treatments. In regards to the specific
approaches to performing such treatment, pooled estimates
from the included studies did not demonstrate significantly
different results for the studied outcomes when performing
PFMT individually or in groups. Such observation is impor-
tant, because group training can potentially reduce costs and
increase availability of such therapy.51 We could not analyze
characteristics such as number of repetitions of number of
sessions, because variability was very large among studies.
Regarding the position inwhich the exercises are performed,
therewas no significant differencewhen performing them in
supine position or when combining both supine and stand-
ing positions. Such observation differed from the initial
hypothesis in the study that assessed this comparison, since
the authors expected that training performed in conditions
that simulated daily activities (and thus, performed while
standing) would result in superior outcomes.20 Exercising in
a more intensive way, supervised by a physical therapist,
when compared with home exercises, had some controver-
sial results. Unfortunately, it was not possible to pool the
studies’ results for some outcomes, and individual studies
differed in their conclusions. Considering individualfindings,
there was no difference between these two modalities in
some studies, while supervised PFMT was better in others.
The only possible combinationwas for the number of women
satisfiedwith their treatment, inwhich supervised PFMTwas
better than home exercises, but there was high statistical
heterogeneity, which limits this conclusion. It is possible that
such heterogeneitymay be related to the individual patients’
abilities to perform their exercises at home, which may have
differed among the studies; an initial supervised training
session, which teaches women how to perform their exer-
cises at home, may also have great influence in the adequacy
of the exercises performed later with no supervision, and
such aspect may have been different among the studies. The
combination of biofeedback techniques during PFMT exer-
cises seems not to lead to systematically better results when
compared with PFMT alone in women that can adequately
contract their pelvic floors, considering the included studies.
Such combination, however, may be an option inwomen that
cannot adequately isolate and contract such muscles. In
these women, any additional benefit seems to be concen-
trated in the first weeks of treatment. Although the benefits
of PFMT exercises usually take some time to become clini-
cally significant, training aimed specifically at performing a
pre-contraction (knack) of the pelvic floor immediately
before straining may be efficacious in decreasing urine loss
rather quickly, although the difference was not statistically
significant in the study that assessed such intervention.
In regards to other techniques that potentiate or replace
PFMT, IES was more efficacious than no treatment, resulting
in better quality of life and in less urine loss observed at pad
tests, according to combined estimates from eligible studies.
There was high heterogeneity in the combination of these
studies, probably related to specific differences in the treat-
ments’ parameters and intensities among different studies,
although they all used high frequency stimulation (around
50Hz) and only differed in treatment durations and pulse
intervals. There was also a smaller number of incontinence
episodes in the combined estimate, but the subjective im-
provement results were controversial among different
studies.
As an alternative to IES, SESwas alsomore efficacious than
no treatment, resulting in better quality of life and in smaller
urine loss at pad tests. Such result should be paid attention
to, since the use of surface electrodes may be an alternative
for women who do not consent with, or who experience
some form of bother or pain with the use intravaginal
electrodes, and for women with vaginal stenosis.40 The
combination of PFMT with IES, when compared with PFMT
alone, could be evaluated through pooled estimates, and
individual studies presented controversial results for all
outcomes. A possible explanation, again, is variability in
the characteristics of the treatments among studies, with
one of them using the intervention twice a day, while
another using it every ten days. We cannot conclude, consid-
ering the data included in the review, that combining IES
with PFMT is superior to PFMT alone – only one out of three
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studies suggested that the combination leads to better
results.33 In the restricted group of postpartum women
with SUI, the use of PFMT techniques appears to be effica-
cious in increasing pelvic floor muscle strength, but there
was no difference in performing these exercises at home,
individually, or in a supervised fashion.
Vaginal cones also had controversial results when
compared with no treatment, with combined estimates
suggesting better quality of life, and a single study sug-
gestive higher subjective improvement after using vaginal
cones. On the other hand, urine loss at pad tests and
number of incontinence episodes were not significantly
better with vaginal cones, when compared with no treat-
ment. Cones, due to their ease of use, may be an alterna-
tive for women that cannot adequately contract their
pelvic floors for performing PFMT, but their results are
less documented. When comparing PFMT and vaginal
cones head to head, and also when comparing IES and
vaginal cones, it was not possible to determine that any of
them is superior to the other, due to lack of significant
differences in any studied outcome. Magnetic stimulation
and the Paula method have very little availability in Brazil,
and have a potentially higher cost when compared with
the other studied interventions. Also, observed results do
not suggested better results for these treatments when
compared with PFMT.
Conclusion
This systematic review is endorsed by the Urogynecology
Committee of the Federação das Associações Brasileiras de
Ginecologia e Obstetrícia (Brazilian Federation of the Socie-
ties of Gynecology and Obstetrics, FEBRASGO) and suggests
that pelvic floor muscle therapy and behavioral therapy
should be the first-line treatment for stress urinary inconti-
nence and subsequent physical therapy techniques (such as
biofeedback, vaginal cones, electrostimulation) are especial-
ly indicatedwhenwomen are not able to voluntarily contract
the pelvic floor muscles.
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